James F. Oliviero III, Chief Financial Officer at KERYX BIOPHARMACEUTICALS INC (KERX), sold 292,483 shares at $15.11 ($4.4M) on 2014-03-21, disclosed to the SEC on 2014-03-21.
Open-market sale of $4.4M KERX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.23 | 154,039 | $2.3M | 53.0% |
| 2 | $15.04 | 125,000 | $1.9M | 42.4% |
| 3 | $15.11 | 13,444 | $203K | 4.6% |
| Total | $15.14 avg | 292,483 | $4.4M | 100% |
| Filing → |
| CKPT | SELL | 2024-12-20 | $6.1M | — | Filing → |
| CKPT | SELL | 2024-06-28 | $101K | — | Filing → |
| CKPT | SELL | 2024-03-01 | $12K | — | Filing → |